首页 | 本学科首页   官方微博 | 高级检索  
     


Benzofuro[3,2-d]pyrimidines inspired from cercosporamide CaPkc1 inhibitor: Synthesis and evaluation of fluconazole susceptibility restoration
Authors:Viet Hung Dao  Isabelle Ourliac-Garnier  Marc-Antoine Bazin  Catherine Jacquot  Blandine Baratte  Sandrine Ruchaud  Stéphane Bach  Olivier Grovel  Patrice Le Pape  Pascal Marchand
Affiliation:1. Université de Nantes, Nantes Atlantique Universités, Département de Chimie Thérapeutique, EA1155 – IICiMed, Institut de Recherche en Santé 2, F-44200 Nantes, France;2. Université de Nantes, Nantes Atlantique Universités, Département de Parasitologie et Mycologie Médicale, EA1155 – IICiMed, Institut de Recherche en Santé 2, F-44200 Nantes, France;3. Sorbonne Université, CNRS, Plateforme de criblage KISSf (Kinase Inhibitor Specialized Screening facility), USR Protein Phosphorylation and Human Diseases, Station Biologique, Place Georges Teissier, F-29688 Roscoff, France;4. Université de Nantes, Nantes Atlantique Universités, EA2160 – Mer Molécules Santé, Faculté de Pharmacie, F 44035 Nantes, France
Abstract:In a context of growing resistance to classical antifungal therapy, the design of new drugs targeting alternative pathways is highly expected. Benzofuro[3,2-d]pyrimidine derivatives, derived from (?)-cercosporamide, were synthesized and evaluated as potential Candida albicans PKC inhibitors in the aim of restoring susceptibility to azole treatment. Co-administration assay of benzofuropyrimidinedione 23 and fluconazole highlighted a synergistic effect on inhibition of cell growth of a Candida albicans resistant strain.
Keywords:Cercosporamide  Antifungal activity  Fluconazole susceptibility restoration
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号